<?xml version="1.0" encoding="UTF-8"?>
<html>
   <head/>
   <body>
      <div class="hl7Message">
         <p>MSH|^~\&amp;|^2.16.840.1.113883.3.72.5.20^ISO|^2.16.840.1.113883.3.72.5.21^ISO||^2.16.840.1.113883.3.72.5.23^ISO|2015092616<br/>0001||ORU^R01^ORU_R01|LRI_5.1_2.1-GU_FRN|D|2.5.1|||AL|AL|||||LRI_Common_Component^^2.16.840.1.113883.9.16^ISO~LRI_GU_Com<br/>ponent^^2.16.840.1.113883.9.12^ISO~LAB_FRN_Component^^2.16.840.1.113883.9.84^ISO<br/>
         </p>
         <p>PID|1||PATID1239^^^&amp;2.16.840.1.113883.3.72.5.30.2&amp;ISO^MR||Smirnoff^Peggy^^^^^L||19750401|F||2106-3^White^HL70005|||||||<br/>|PATID1239^^^&amp;2.16.840.1.113883.3.72.5.30.2&amp;ISO^AN<br/>
         </p>
         <p>ORC|RE|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||5742200012^Radon^Nicho<br/>las^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI<br/>
         </p>
         <p>OBR|1|ORD448811^^2.16.840.1.113883.3.72.5.24^ISO|R-511^^2.16.840.1.113883.3.72.5.25^ISO|HepABC Panel^Hepatitis A B C Pa<br/>nel^L|||20150925|||||||||5742200012^Radon^Nicholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI||||||20150926140500-0800|||<br/>F<br/>
         </p>
         <p>OBX|1|CWE|22314-9^Hepatitis A virus IgM Ab [Presence] in Serum^LN^HAVM^Hepatitis A IgM antibodies (IgM anti-HAV)^L^2.52<br/>||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150<br/>925|||||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^<br/>CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|2|CWE|20575-7^Hepatitis A virus Ab [Presence] in Serum^LN^HAVAB^Hepatitis A antibodies (anti-HAV)^L^2.52||260385009<br/>^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925|||||201<br/>509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^US<br/>A^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|3|CWE|16933-4^Hepatitis B virus core Ab [Presence] in Serum^LN^HBVcAB^Hepatitis B core antibodies (anti-HBVc)^L^2.5<br/>2||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||2015<br/>0925|||||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles<br/>^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|4|SN|22316-4^Hepatitis B virus core Ab [Units/volume] in Serum^LN^HBcAbQ^Hepatitis B core antibodies (anti-HBVc) Qu<br/>ant^L^2.52||^0.40|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L^1.9|&lt;0.50 IU/mL|N|||F|||20150925|||||201509261<br/>400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90067^USA^B^^0<br/>6037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|5|CWE|22320-6^Hepatitis B virus e Ab [Presence] in Serum^LN^HBVeAB^Hepatitis B e antibodies (anti-HBVe)^L^2.52||260<br/>385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||20150925||<br/>|||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^90<br/>067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|6|CWE|5195-3^Hepatitis B virus surface Ag [Presence] in Serum^LN^HBVsAG^Hepatitis B surface antigen (HBsAg)^L^2.52|<br/>|260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||201509<br/>25|||||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^C<br/>A^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|7|CWE|22322-2^Hepatitis B virus surface Ab [Presence] in Serum^LN^HBVSAB^Hepatitis B surface antibody (anti-HBVs)^L<br/>^2.52||260385009^Negative (qualifier value)^SCT^NEG^NEGATIVE^L^201509USEd^^Negative (qualifier value)||Negative|N|||F|||<br/>20150925|||||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Ang<br/>eles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|8|CWE|16128-1^Hepatitis C virus Ab [Presence] in Serum^LN^HCVAB^Hepatitis C antibody screen  (anti-HCV)^L^2.52||108<br/>28004^Positive (qualifier value)^SCT^POS^POSITIVE^L^201509USEd^^Positive (qualifier value)||Negative|A|||F|||20150925|||<br/>||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^900<br/>67^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>OBX|9|SN|48159-8^Hepatitis C virus Ab Signal/Cutoff in Serum or Plasma by Immunoassay^LN^HCVSCO^Hepatitis C antibodies <br/>Signal to Cut-off Ratio^L^2.52||^10.8|{s_co_ratio}^Signal to cutoff ratio^UCUM^s/co^^L^1.9|0.0-0.9 s/co|H|||F|||20150925<br/>|||||201509261400||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Test Park^^Los Angeles^CA^<br/>90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>NTE|1||Negative:   &lt; 0.8; Indeterminate 0.8 - 0.9; Positive:  &gt; 0.9<br/>
         </p>
         <p>NTE|2||In order to reduce the incidence of a false positive result, the CDC recommends that all s/co ratios between 1.0<br/> and 10.9 be confirmed with additional Verification or PCR testing.<br/>
         </p>
         <p>SPM|1|S-2015-666666&amp;&amp;2.16.840.1.113883.3.72.5.24&amp;ISO^S-991133&amp;&amp;2.16.840.1.113883.3.72.5.25&amp;ISO||119364003^Serum specime<br/>n (specimen)^SCT^SER^Serum^L^201509USEd|||||||||||||20150925<br/>
         </p>
         <p>ORC|RE||R-511^^2.16.840.1.113883.3.72.5.25^ISO|||||||||5742200012^Radon^Nicholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^<br/>NPI|||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L<br/>
         </p>
         <p>OBR|2||R-511^^2.16.840.1.113883.3.72.5.25^ISO|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Pla<br/>sma by Probe and target amplification method^LN^HCVRNA^Hepatitis C RNA PCR^L^2.52|||20150925||||G|||||5742200012^Radon^N<br/>icholas^^^DR^^^&amp;2.16.840.1.113883.4.6&amp;ISO^L^^^NPI||||||20150929102500|||F|48159-8&amp;Hepatitis C virus Ab Signal/Cutoff in <br/>Serum or Plasma by Immunoassay&amp;LN&amp;HCVSCO&amp;Hepatitis C antibodies Signal to Cut-off Ratio&amp;L&amp;2.52|||ORD448811&amp;&amp;2.16.840.1.1<br/>13883.3.72.5.24&amp;ISO^R-511&amp;&amp;2.16.840.1.113883.3.72.5.25&amp;ISO|||||||||||||||||||||HepABC Panel^Hepatitis A B C Panel^L<br/>
         </p>
         <p>OBX|1|SN|11011-4^Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification<br/> method^LN^HCVRNA^Hepatitis C RNA PCR^L^2.52||^7611200|[IU]/mL^international unit per milliliter^UCUM^IU/ml^^L^1.9|&lt;43 I<br/>U/mL|H|||F|||20150925|||||20120629092700||||Century Hospital^^^^^CLIA&amp;2.16.840.1.113883.4.7&amp;ISO^XX^^^24D9871327|2070 Tes<br/>t Park^^Los Angeles^CA^90067^USA^B^^06037|^Knowsalot^Phil^J.^^Dr.||||RSLT<br/>
         </p>
         <p>SPM|1|S-2015-666666&amp;&amp;2.16.840.1.113883.3.72.5.24&amp;ISO^S-991133&amp;&amp;2.16.840.1.113883.3.72.5.25&amp;ISO||119364003^Serum specime<br/>n (specimen)^SCT^SER^Serum^L^201509USEd|||||||||||||20150925<br/>
         </p>
      </div>
   </body>
</html>